CNPPD1

gene
On this page

Also known as CGI-57

Summary

CNPPD1 (cyclin Pas1/PHO80 domain containing 1, HGNC:25220) is a protein-coding gene on chromosome 2q35, encoding Protein CNPPD1 (Q9BV87).

Predicted to enable cyclin-dependent protein serine/threonine kinase regulator activity. Predicted to be located in membrane. Predicted to be part of cyclin-dependent protein kinase holoenzyme complex. Predicted to be active in nucleus.

Source: NCBI Gene 27013 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 88 total
  • MANE Select transcript: NM_015680

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25220
Approved symbolCNPPD1
Namecyclin Pas1/PHO80 domain containing 1
Location2q35
Locus typegene with protein product
StatusApproved
AliasesCGI-57
Ensembl geneENSG00000115649
Ensembl biotypeprotein_coding
Entrez27013

Gene structure

Transcript identifiers

Ensembl transcripts: 14 — 14 protein_coding

ENST00000360507, ENST00000409789, ENST00000451647, ENST00000453038, ENST00000874461, ENST00000874462, ENST00000874463, ENST00000874464, ENST00000874465, ENST00000874466, ENST00000874467, ENST00000874468, ENST00000922693, ENST00000960025

RefSeq mRNA: 4 — MANE Select: NM_015680 NM_001321389, NM_001321390, NM_001321391, NM_015680

CCDS: CCDS2433

Canonical transcript exons

ENST00000360507 — 8 exons

ExonStartEnd
ENSE00000785973219176223219176331
ENSE00000785974219175591219175672
ENSE00000785975219174988219175108
ENSE00000785979219174146219174207
ENSE00000785980219173350219173467
ENSE00001075441219174778219174906
ENSE00001433017219171897219173128
ENSE00001433990219176760219176925

Expression profiles

Bgee: expression breadth ubiquitous, 285 present calls, max score 97.19.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 19.0399 / max 167.2645, expressed in 1811 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
3402611.95461796
340294.48131621
340251.3214908
340271.2826803

Top tissues by expression

295 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mucosa of transverse colonUBERON:000499197.19gold quality
right adrenal glandUBERON:000123397.02gold quality
right adrenal gland cortexUBERON:003582796.94gold quality
left adrenal glandUBERON:000123496.89gold quality
left adrenal gland cortexUBERON:003582596.69gold quality
lower esophagus mucosaUBERON:003583496.66gold quality
metanephros cortexUBERON:001053396.62gold quality
granulocyteCL:000009496.48gold quality
adrenal cortexUBERON:000123596.48gold quality
apex of heartUBERON:000209896.34gold quality
transverse colonUBERON:000115796.18gold quality
lower esophagusUBERON:001347396.16gold quality
lower esophagus muscularis layerUBERON:003583396.15gold quality
mucosa of stomachUBERON:000119995.96gold quality
right lobe of thyroid glandUBERON:000111995.82gold quality
small intestine Peyer’s patchUBERON:000345495.82gold quality
esophagogastric junction muscularis propriaUBERON:003584195.74gold quality
bloodUBERON:000017895.72gold quality
monocyteCL:000057695.70gold quality
esophagusUBERON:000104395.70gold quality
skin of legUBERON:000151195.70gold quality
esophagus mucosaUBERON:000246995.55gold quality
leukocyteCL:000073895.49gold quality
right coronary arteryUBERON:000162595.47gold quality
mononuclear cellCL:000084295.42gold quality
gastrocnemiusUBERON:000138895.40gold quality
adrenal glandUBERON:000236995.31gold quality
left lobe of thyroid glandUBERON:000112095.25gold quality
adult mammalian kidneyUBERON:000008295.16gold quality
renal medullaUBERON:000036295.14gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-GEOD-110499no710.50
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

34 targeting CNPPD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6758-5P100.0066.211470
HSA-MIR-6856-5P100.0065.471298
HSA-MIR-607799.9968.042299
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-6764-5P99.7567.892304
HSA-MIR-128399.6972.423009
HSA-MIR-453099.6966.471509
HSA-MIR-7-5P99.6770.531809
HSA-MIR-452-5P99.6569.631762
HSA-MIR-4676-3P99.6569.311733
HSA-MIR-892C-3P99.6569.381745
HSA-MIR-1915-3P99.5866.791988
HSA-MIR-510-3P99.5470.062965
HSA-MIR-5584-5P99.4968.222814
HSA-MIR-548G-3P99.4868.672159
HSA-MIR-548B-3P99.3867.261000
HSA-MIR-532-3P99.3465.761195
HSA-MIR-125399.1267.081688
HSA-MIR-316899.0867.751384
HSA-MIR-3117-5P99.0467.93618
HSA-MIR-4738-3P98.9867.981846
HSA-MIR-7851-3P98.7264.88980
HSA-MIR-6840-3P98.6865.951923
HSA-MIR-446398.5666.051071
HSA-MIR-1910-3P98.4467.511695
HSA-MIR-427798.3467.171323
HSA-MIR-6732-3P98.1767.52802
HSA-MIR-6511A-5P98.1367.471770
HSA-MIR-1224-3P97.2465.92851
HSA-MIR-4433B-3P97.2263.62663

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriocnppd1ENSDARG00000027078
mus_musculusCnppd1ENSMUSG00000033159
rattus_norvegicusCnppd1ENSRNOG00000018325
drosophila_melanogasterCG40191FBGN0058191
caenorhabditis_elegansWBGENE00017311

Protein

Protein identifiers

Protein CNPPD1Q9BV87 (reviewed: Q9BV87)

Alternative names: Cyclin Pas1/PHO80 domain-containing protein 1

All UniProt accessions (3): C9J597, C9JF31, Q9BV87

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Similarity. Belongs to the CNPPD1 family.

RefSeq proteins (4): NP_001308318, NP_001308319, NP_001308320, NP_056495* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR013922Cyclin_PHO80-likeFamily

Pfam: PF08613

UniProt features (8 total): sequence variant 5, chain 1, transmembrane region 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BV87-F169.880.35

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 156 (showing top): GCM_GSPT1, MORF_SNRP70, MORF_UBE2I, FOXO4_01, FREAC3_01, USF_01, HFH4_01, GCM_DDX11, SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP, NRF2_01, GCM_NF2, MORF_PDPK1, MORF_IKBKG, MORF_AATF, CTTTGTA_MIR524

GO Biological Process (1): regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)

GO Molecular Function (2): cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538), protein kinase binding (GO:0019901)

GO Cellular Component (3): cyclin-dependent protein kinase holoenzyme complex (GO:0000307), nucleus (GO:0005634), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cyclin-dependent protein serine/threonine kinase activity2
regulation of protein serine/threonine kinase activity1
cyclin-dependent protein kinase regulator activity1
kinase binding1
serine/threonine protein kinase complex1
intracellular membrane-bounded organelle1
cellular anatomical structure1

Protein interactions and networks

STRING

878 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CNPPD1SMIM14Q96QK8546
CNPPD1RCC1LQ96I51452
CNPPD1LRRC70Q7Z2Q7434
CNPPD1DTD2Q96FN9405
CNPPD1TPGS2Q68CL5397
CNPPD1CCNJLQ8IV13377
CNPPD1ZNF90Q03938370
CNPPD1TMEM185AQ8NFB2370
CNPPD1SLC23A3Q6PIS1368
CNPPD1CCDC146Q8IYE0360
CNPPD1CCDC186Q7Z3E2348
CNPPD1INO80DQ53TQ3320
CNPPD1LRPAP1P30533317
CNPPD1TESK1Q15569313
CNPPD1DNAJB14Q8TBM8313

IntAct

5 interactions, top by confidence:

ABTypeScore
CNPPD1SLC27A2psi-mi:“MI:0914”(association)0.530
CNPPD1TNNC2psi-mi:“MI:0914”(association)0.350
RSPH1CNPPD1psi-mi:“MI:0915”(physical association)0.000

BioGRID (13): UBB (Affinity Capture-MS), OMA1 (Affinity Capture-MS), SLC27A2 (Affinity Capture-MS), CDK5 (Affinity Capture-MS), PLS1 (Affinity Capture-MS), PLS1 (Affinity Capture-MS), UBB (Affinity Capture-MS), CDK5 (Affinity Capture-MS), OMA1 (Affinity Capture-MS), SLC27A2 (Affinity Capture-MS), TNNC2 (Affinity Capture-MS), CNPPD1 (Affinity Capture-RNA), CNPPD1 (Two-hybrid)

ESM2 similar proteins: D4A929, E1BP92, E1CHH8, O15037, O95238, P29473, P57059, P60924, P97270, Q14154, Q15572, Q2LGB3, Q4JF29, Q4R6Y5, Q562E7, Q58EX7, Q5E9J2, Q5HZE8, Q5JYT7, Q5ND34, Q5R4U5, Q5XIS1, Q5ZJH7, Q62406, Q6P773, Q6P7B2, Q6PDZ2, Q6ZS11, Q7TNI2, Q7TSI1, Q80UF7, Q80UW3, Q8BLR5, Q8BSD4, Q8CFK6, Q8IUC6, Q8K158, Q8K330, Q8NDX1, Q8TB24

Diamond homologs: Q5E9J2, Q5R4U5, Q5ZJH7, Q6P7B2, Q75HV0, Q8K158, Q9BV87

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

88 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance69
Likely benign6
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2013 predictions. Top by Δscore:

VariantEffectΔscore
2:219173126:CAG:Cacceptor_gain1.0000
2:219173346:TCACC:Tdonor_loss1.0000
2:219173348:A:Tdonor_loss1.0000
2:219173349:C:CAdonor_loss1.0000
2:219173463:CCACA:Cacceptor_gain1.0000
2:219173464:CACA:Cacceptor_gain1.0000
2:219173464:CACAC:Cacceptor_gain1.0000
2:219173465:ACA:Aacceptor_gain1.0000
2:219173466:CA:Cacceptor_gain1.0000
2:219173466:CAC:Cacceptor_gain1.0000
2:219173468:C:CCacceptor_gain1.0000
2:219173468:CTG:Cacceptor_loss1.0000
2:219173477:G:GCacceptor_gain1.0000
2:219174145:CCAG:Cdonor_gain1.0000
2:219175105:CTCC:Cacceptor_gain1.0000
2:219175106:TCC:Tacceptor_gain1.0000
2:219175107:CC:Cacceptor_gain1.0000
2:219175107:CCC:Cacceptor_gain1.0000
2:219175108:CC:Cacceptor_gain1.0000
2:219175109:C:CCacceptor_gain1.0000
2:219175589:A:ACdonor_gain1.0000
2:219175590:C:CCdonor_gain1.0000
2:219175668:AATGT:Aacceptor_gain1.0000
2:219175669:ATGT:Aacceptor_gain1.0000
2:219175670:TGT:Tacceptor_gain1.0000
2:219175670:TGTC:Tacceptor_loss1.0000
2:219175671:GT:Gacceptor_gain1.0000
2:219175672:TCTGC:Tacceptor_loss1.0000
2:219175673:C:CAacceptor_loss1.0000
2:219175673:C:CCacceptor_gain1.0000

AlphaMissense

2625 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:219174844:C:AW148C0.999
2:219174844:C:GW148C0.999
2:219174846:A:GW148R0.999
2:219174846:A:TW148R0.999
2:219174892:C:AK132N0.998
2:219174892:C:GK132N0.998
2:219174791:A:GF166S0.997
2:219174891:A:CY133D0.997
2:219174895:A:CS131R0.997
2:219174895:A:TS131R0.997
2:219174897:T:GS131R0.997
2:219174899:G:TA130D0.997
2:219175001:A:GF123S0.997
2:219173462:G:TA193D0.996
2:219174799:C:AE163D0.996
2:219174799:C:GE163D0.996
2:219174845:C:GW148S0.996
2:219174894:T:CK132E0.996
2:219175000:G:CF123L0.996
2:219175000:G:TF123L0.996
2:219175002:A:GF123L0.996
2:219175052:A:GL106P0.996
2:219174204:A:GW172R0.995
2:219174204:A:TW172R0.995
2:219174790:G:CF166L0.995
2:219174790:G:TF166L0.995
2:219174792:A:GF166L0.995
2:219174887:A:GL134P0.995
2:219174893:T:AK132M0.995
2:219174998:A:GL124P0.995

dbSNP variants (sampled 300 via entrez): RS1000271328 (2:219176030 T>C), RS1001437508 (2:219175922 C>A,T), RS1001505823 (2:219174614 C>T), RS1001870314 (2:219176176 C>T), RS1002005708 (2:219172500 G>A), RS1002996102 (2:219174377 C>A,T), RS1003270513 (2:219179255 T>A), RS1003447924 (2:219178090 C>A,G,T), RS1003798270 (2:219173829 C>A), RS1003821548 (2:219177824 C>A), RS1003824102 (2:219177779 A>G), RS1004064772 (2:219177978 A>C,G), RS1004828023 (2:219178529 G>A), RS1005044696 (2:219173633 TTTTATTTATTTTTA>T), RS1005063731 (2:219174010 G>A)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST012226_198Waist circumference adjusted for body mass index1.000000e-08
GCST90002400_343Plateletcrit5.000000e-12
GCST90002402_289Platelet count4.000000e-15

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0007789BMI-adjusted waist circumference
EFO:0007985platelet crit
EFO:0004309platelet count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

15 total (human), top 15 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases abundance, increases expression2
Air Pollutantsincreases expression, increases abundance2
Valproic Acidaffects expression, decreases expression2
triphenyl phosphateaffects expression1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic acidincreases expression1
abrineincreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic aciddecreases expression1
Arsenicincreases abundance, increases expression1
Drugs, Chinese Herbalincreases expression1
Smokeincreases abundance, increases expression1
Tobacco Smoke Pollutionincreases expression1
Cadmium Chlorideincreases expression1
Lactic Aciddecreases expression1
Particulate Matterincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.